Skip to main content
Search
Newsletters
Watchlist
Latest in
Merck
Follow
You must be logged in to follow.
Log In
Create free account
Latest
report on business
Geneos cancer vaccine shrinks liver tumors in small trial
April 7, 2024
world
Merck’s Keytruda combo gets U.S. FDA nod for expanded use in cervical cancer
January 12, 2024
international business
Merck signs US$5.5-billion deal with Daiichi Sankyo for cancer therapy development
October 20, 2023
u.s. business
U.S. plans shift of Merck’s COVID-19 treatment to commercial market
October 4, 2023
advisor etfs
Expanding array of services for pets offers investors chance to get in on sector’s growth
May 31, 2023
international business
Drugmaker Merck tops first-quarter expectations on Keytruda, Gardasil strength
April 27, 2023
international business
U.S. FDA pauses initiation of new patients on Merck’s MS drug, sending shares plunging
April 12, 2023
international business
Pfizer reportedly in talks to buy cancer drugmaker Seagen
February 27, 2023
world
EU drug regulator recommends against approval for Merck’s COVID-19 pill for adults
February 24, 2023
world
Merck and Moderna detail progress on potential skin cancer vaccine
December 13, 2022
world
Dozens of firms to make cheap version of Merck COVID-19 pill for poorer nations
January 20, 2022
world
Merck’s at-home antiviral COVID-19 pill authorized by U.S. FDA
December 23, 2021
market news
The close: North American markets rise as Omicron fears subside; ‘Santa Claus rally’ may be muted
December 22, 2021
canada
Canada to manufacture Merck COVID-19 antivirals if regulator approves
December 6, 2021
canada
Canada buying up to 1.5 million courses of oral anti-viral drugs to fight COVID-19
December 3, 2021
international business
Pfizer, U.S. ink US$5.29-billion deal over possible COVID-19 treatment
November 18, 2021
world
Merck ahead of Pfizer in EU talks on COVID-19 pills
November 8, 2021
world
Pfizer says its experimental antiviral pill for COVID-19 cuts risk of hospitalization, death by 89%
November 5, 2021